Abstract
Signaling via notch receptors and their ligands is an evolutionary ancient and highly conserved mechanism governing cell-fate decisions throughout the animal kingdom. Upon ligand binding, notch receptors are subject to a two-step proteolysis essential for signal transduction. First, the ectodomain is removed by an enzyme cleaving near the outer-membrane surface (“site2”). Consecutively, the notch intracellular domain is liberated by a second protease cutting within the transmembrane sequence (“site3”). The intracellular domain is then transferred to the nucleus to act as a transcriptional coactivator. The proteases involved in notch receptor activation are shared with other proteins undergoing regulated intramembrane proteolysis, with intriguing parallels to APP. Specifically, site3 cleavage of Notch, as well as γ-secretase processing of APP depend both critically on presenilins 1 and 2. Moreover, ADAM 10 and ADAM 17, the proteases proposed to perform site2 cleavage, are also the most probable candidate α-secretases to cleave APP.
While the biological significance of APP processing remains to be further elucidated, interference with notch signaling has been shown to have severe consequences both in small animal models as well as in humans. Thus, a growing number of long known genetic syndromes like Alagille syndrome or Fallot’s tetralogy can be caused by mutations of genes relevant for the notch signaling pathway. Likewise, the anticipated interference of γ-secretase inhibitors with site3 cleavage may turn out to be a major obstacle for this therapeutic approach to Alzheimer’s disease.
Similar content being viewed by others
References
Artavanis-Tsakonas S., Rand M. D., and Lake R. J. (1999) Notch signaling: cell fate control and signal integration in development. Science 284, 770–776.
Baumeister R., Leimer U., Zweckbronner I., Jakubek C., Grunberg J., and Haass C. (1997) Human presenilin-1, but not familial Alzheimer’s disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. Genes Funct. 1, 149–159.
Berechid B. E., Thinakaran G., Wong P. C., Sisodia S. S., and Nye J. S. (1999) Lack of requirement for presenilin1 in Notch1 signaling. Curr. Biol. 9, 1493–1496.
Blaumueller C. M., Qi H., Zagouras P., and Artavanis-Tsakonas S. (1997) Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell 90, 281–291.
Borchelt D. R., Ratovitski T., van Lare J., Lee M. K., Gonzales V., Jenkins N. A., et al. (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 19, 939–945.
Brou C., Logeat F., Gupta N., Bessia C., LeBail O., Doedens J. R., et al. (2000) A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrinmetalloprotease TACE. Mol. Cell. 5, 207–216.
Brown M. S., Ye J., Rawson R. B., and Goldstein J. L. (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391–398.
Bulman M. P., Kusumi K., Frayling T. M., McKeown C., Garrett C., Lander E. S., et al. (2000) Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat. Genet. 24, 438–441.
Bush G., diSibio G., Miyamoto A., Denault J. B., Leduc R., and Weinmaster G. (2001) Ligand-induced signaling in the absence of furin processing of Notch1. Dev. Biol. 229, 494–502.
Buxbaum, J. D., et al. (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 27,765–27,767.
Cai H., Wang Y., McCarthy D., Wen H., Borchelt D. R., Price D. L., and Wong P. C. (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat. Neurosci. 4, 233–234.
Capell A., Grunberg J., Pesold B., Diehlmann A., Citron M., Nixon R., et al. (1998) The proteolytic fragments of the Alzheimer’s disease-associated presenilin-1 form heterodimers and occur as a 100–150-kDa molecular mass complex. J. Biol. Chem. 273, 3205–3211.
Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., et al. (1997) Mutant presenilins of Alzheimer’s disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3, 67–72.
Conlon R. A., Reaume A. G., and Rossant J. (1995) Notch1 is required for the coordinate segmentation of somites. Development 121, 1533–1545.
De Strooper B. and Annaert W. (2000) Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci. 113, 1857–1870.
De Strooper B. and Annaert W. (2001) Where Notch and Wnt signaling meet. The presenilin hub. J. Cell Biol. 152, F17-F20.
De Strooper B., Annaert W., Cupers P., Saftig P., Craessaerts K., Mumm J. S., et al. (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518–522.
De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., et al. (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387–390.
Dominguez D. I., De Strooper B., and Annaert W. (2001) Secretases as therapeutic targets for the treatment of Alzheimer’s disease. Amyloid 8, 124–142.
Donoviel D. B., Hadjantonakis A. K., Ikeda M., Zheng H., Hyslop P. S., and Bernstein A. (1999) Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 13, 2801–2810.
Duff K., Eckman C., Zehr C., Yu X., Prada C. M., Pereztur J., et al. (1996) Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710–713.
Ellisen L. W., Bird J., West D. C., Soreng A. L., Reynolds T. C., Smith S. D., and Sklar J. (1991) TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66, 649–661.
Eldadah Z. A., Hamosh A., Biery N. J., Montgomery R. A., Duke M., Elkins R., and Dietz H. C. (2001) Familial Tetralogy of Fallot caused by mutation in the jagged1 gene. Hum. Mol. Genet. 10, 163–169.
Elser W. P., Kimberly W. T., Ostaszewski B. L., Diehl T. S., Moore C. L., Tsai J. Y., et al. (2000) Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1. Nat. Cell Biol. 2, 428–434.
Fryxell K. J., Soderlund M., and Jordan T. V. (2001) An animal model for the molecular genetics of CADASIL. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 32, 6–11.
Hadland B. K., Manley N. R., Su D., Longmore G. D., Moore C. L., Wolfe M. S., et al. (2001) Gammasecretase inhibitors repress thymocyte development. Proc. Natl. Acad. Sci. USA 98, 7487–7491.
Hartmann D., De Strooper B., and Saftig P. (1999) Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly. Curr. Biol. 9, 719–727.
Heber S., Herms J., Gajic V., Hainfellner J., Aguzzi A., Rulicke T., et al. (2000) Mice with combined gene knockouts reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20, 7951–7963.
Herreman A., Hartmann D., Annaert W., Saftig P., Craessaerts K., Serneels L., et al. (1999) Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl. Acad. Sci. USA 96, 11,872–11,877.
Herreman A., Serneels L., Annaert W., Collen D., Schoonjans L., and De Strooper B. (2000) Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat. Cell Biol. 2, 461–462.
Joutel A., Vahedi K., Corpechot C., Troesch A., Chabriat H., Vayssiere C., et al. (1997) Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 350, 1511–1515.
Joutel A., Andreux F., Gaulis S., Domenga V., Cecillon M., Battail N., et al. (2000) The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J. Clin. Invest. 105, 597–605.
Kiernan A. E., Ahituv N., Fuchs H., Balling R., Avraham K. B., Steel K. P., and Hrabe de Angelis M. (2001) The Notch ligand Jagged1 is required for inner ear sensory development. Proc. Natl. Acad. Sci. USA 98, 3873–3878.
Koike H. S., Koike H., Tomioka S., Sorimachi H., Saido T. C., Maruyama K., et al. (1999) Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem. J. 343, 371–375.
Krebs L. T., Xue Y., Norton C. R., Shutter J. R., Maguire M., Sundberg J. P., et al. (2000) Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14, 1343–1352.
Kulic L., Walter J., Multhaup G., Teplow D. B., Baumeister R., Romig H., et al. (2000) Separation of presenilin function in amyloid beta-peptide generation and endoproteolysis of Notch. Proc. Natl. Acad. Sci. USA 97, 5913–5918.
Kusumi K., Sun E. S., Kerrebrock A. W., Bronson R. T., Chi D. C., Bulotsky M. S., et al. (1998) The mouse pudgy mutation disrupts Delta homologue Dll3 and initiation of early somite boundaries. Nat. Genet. 19, 274–278.
Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., et al. (1999) Constitutive and regulated alpha-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. USA 96, 3922–3927
Levitan D. and Greenwald I. (1995) Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer’s disease gene. Nature 377, 351–354.
Levitan D., Doyle T. G., Brousseau D., Lee M. K., Thinakaran G., Slunt H. H., et al. (1996) Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 93, 14,940–14,944.
Li X. and Greenwald I. (1997) HOP-1, a Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signaling. Proc. Natl. Acad. Sci. USA 94, 12,204–12,209.
Li L., Krantz I. D., Deng Y., Genin A., Banta A. B., Collins C. C., et al. (1997) Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 16, 243–251.
Li Y. M., Xu M., Lai M. T., Huang Q., Castro J. L., DiMuzio-Mower J., et al. (2000) Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405, 689–694.
Li Y. M., Lai M. T., Xu M., Huang Q., DiMuzio-Mower J., Sardana M. K., et al. (2000) Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc. Natl. Acad. Sci. USA 97, 6138–6143.
Logeat F., Bessia C., Brou C., LeBail O., Jarriault S., Seidah N. G., and Israel A. (1998) The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc. Natl. Acad. Sci. USA 95, 8108–8112.
Luo Y., Bolon B., Kahn S., Bennett B. D., Babu-Khan S., Denis P., et al. (2001) Mice deficient in BACE1, the Alzheimer’s beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat. Neurosci. 4, 231–232.
Moohr O. L. (1919) Genetics 4, 252.
Muller U., Cristina N., Li Z. W., Wolfer D. P., Lipp H. P., Rulicke T., et al. (1994) Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene. Cell 79, 755–765.
Mumm J. S., Schroeter E. H., Saxena M. T., Griesemer A., Tian X., Pan D. J., et al. (2000) A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol. Cell. 5, 197–206.
Naruse S., Thinakaran G., Luo J. J., Kusiak J. W., Tomita T., Iwatsubo T., et al. (1998) Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21, 1213–1221.
Niwa M., Sidrauski C., Kaufman R. J., and Walter P. (1999) A role for presenilin-1 in nuclear accumulation of Ire1 fragments and induction of the mammalian unfolded protein response. Cell 99, 691–702.
Pan D. and Rubin G. M. (1997) Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 90, 271–280.
Peschon J. J., Slack J. L., Reddy P., Stocking K. L., Sunnarborg S. W., Lee D. C., et al. (1998) An essential role for ectodomain shedding in mammalian development. Science 282, 1281–1284.
Petit A., Bihel F., da Costa C. A., Pourquie O., Checler F., and Kraus J. L. (2001) New protease inhibitors prevent gamma-secretase-mediated production of Abeta40/42 without affecting Notch cleavage. Nat. Cell Biol. 3, 507–511.
Poulson D. F. (1937) Chromosomal deficiencies and the embryonic development of Drosophila melanogaster Proc. Natl. Acad. Sci. USA 23, 133–137.
Pourquie O. (2000) Skin development: delta laid bare. Curr. Biol. 10, R425-R428.
Price D. L., Tanzi R. E., Borchelt D. R., and Sisodia S. S. (1998) Alzheimer’s disease: genetic studies and transgenic models. Annu. Rev. Genet. 32, 461–493.
Qi H., Rand M. D., Wu X., Sestan N., Wang W., Rakic P., Xu T., and Artavanis-Tsakonas S. (1999) Processing of the notch ligand delta by the metalloprotease Kuzbanian. Science 283, 91–94.
Rand M. D., Grimm L. M., Artavanis-Tsakonas S., Patriub V., Blacklow S. C., Sklar J., and Aster J. C. (2000) Calcium depletion dissociates and activates heterodimeric notch receptors. Mol. Cell Biol. 20, 1825–1835.
Roberds S. L., Anderson J., Basi G., Bienkowski M. J., Branstetter D. G., Chen K. S., et al. (2001) BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer’s disease therapeutics. Hum. Mol. Genet. 10, 1317–1324.
Robey E., Chang D., Itano A., Cado D., Alexander H., Lans D., Weinmaster G., and Salmon P. (1996) An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell 87, 483–492.
Robey E. (1997) Notch in vertebrates. Curr. Opin. Genet. Dev. 7, 551–557.
Robson MacDonald H., Wilson A., and Radtke F. (2001) Notch1 and T-cell development: insights from conditional knockout mice. Trends Immunol. 22, 155–160.
Rooke J., Pan D., Xu T., and Rubin G. M. (1996) KUZ, a conserved metalloprotease-disintegrin protein with two roles in Drosophila neurogenesis Science 273, 1227–1231.
Sakai J., Rawson R. B., Espenshade P. J., Cheng D., Seegmiller A. C., Goldstein J. L., and Brown M. S. (1998) Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells. Mol. Cell. 2, 505–514.
Sato N., Urano F., Yoon Leem J., Kim S. H., Li M., Donoviel D., et al. (2000) Upregulation of BiP and CHOP by the unfolded-protein responseis independent of presenilin expression. Nat. Cell Biol. 2, 863–870.
Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., et al. (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat. Med. 2, 864–870.
Schroeter E. H., Kisslinger J. A., and Kopan R. (1998) Notch1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393, 382–386.
Selkoe D. J. (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol. Rev. 81, 741–766.
Shen J., Bronson R. T., Chen D. F., Xia W., Selkoe D. J., and Tonegawa S. (1997) Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89, 629–639.
Song W., Nadeau P., Yuan M., Yang X., Shen J., and Yankner B. A. (1999) Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. Proc. Natl. Acad. Sci. USA 96, 6959–6963.
Soriano S., Kang D. E., Fu M., Pestell R., Chevallier N., Zheng H., and Koo E. H. (2001) Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing. J. Cell Biol. 152, 785–794.
Sotillos S., Roch F., and Campuzano S. (1997) The metalloprotease-disintegrin Kuzbanian participates in Notch activation during growth and patterning of Drosophila imaginal discs. Development 124, 4769–4779.
Struhl G. and Adachi A. (2000) Requirements for presenilin-dependent cleavage of notch and other trans-membrane proteins. Mol. Cell. 6, 625–636.
Struhl G. and Greenwald I. (1999) Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398, 522–525.
Struhl G. and Greenwald I. (2001) Presenilin-mediated transmembrane cleavage is required for Notch signal transduction in Drosophila. Proc. Natl. Acad. Sci. USA 98, 229–234.
Swiatek P. J., Lindsell C. E., del Amo F. F., Weinmaster G., and Gridley T. (1994) Notch1 is essential for post-implantation development in mice. Genes Dev. 8, 707–719.
Takahashi Y., Koizumi K., Takagi A., Kitajima S., Inoue T., Koseki H., and Saga Y. (2000) Mesp2 initiates somite segmentation through the Notch signalling pathway. Nat. Genet. 25, 390–396.
Tsai H., Hardisty R. E., Rhodes C., Kiernan A. E., Roby P., Tymowska-Lalanne Z., et al. (2001) The mouse slalom mutant demonstrates a role for Jagged1 in neuroepithelial patterning in the organ of Corti. Hum. Mol. Genet. 10, 507–512.
Uyttendaele H., Marazzi G., Wu G., Yan Q., Sassoon D., and Kitajewski J. (1996) Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 122, 2251–2259.
von Koch C. S., Zheng H., Chen H., Trumbauer M., Thinakaran G., van der Ploeg L. H., et al. (1997) Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol. Aging 18, 661–669.
Wen C., Metzstein M. M., and Greenwald I. (1997) SUP-17, a Caenorhabditis elegans ADAM protein related to Drosophila KUZBANIAN, and its role in LIN-12/NOTCH signalling. Development 124, 4759–4767.
Wolfe M. S., Xia W., Ostaszewski B. L., Diehl T. S., Kimberly W. T., and Selkoe D. J. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398, 513–517.
Wong P. C., Zheng H., Chen H., Becher M. W., Sirinathsinghji D. J., Trumbauer M. E., et al. (1997) Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387, 288–292.
Ye J., Rawson R. B., Komuro R., Chen X., Dave U. P., Prywes R., et al. (2000) ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol. Cell 6, 1355–1364.
Ye Y., Lukinova N., and Fortini M. E. (1999) Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants. Nature 398, 525–529.
Yu G., Nishimura M., Arawaka S., Levitan D., Zhang L., Tandon A., et al. (2000) Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 407, 48–54.
Yu G., Chen F., Levesque G., Nishimura M., Zhang D. M., Levesque L., et al. (1998) The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. J. Biol. Chem. 273, 16,470–16,475.
Zhang Z., Nadeau P., Song W., Donoviel D., Yuan M., Bernstein A., and Yankner B. A. (2000) Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1. Nat. Cell Biol. 2, 463–465.
Zhao J., Chen H., Peschon J. J., Shi W., Zhang Y., Frank S. J., and Warburton D. (2001) Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis. Dev. Biol. 232, 204–218.
Zheng H., Jiang M., Trumbauer M. E., Sirinathsinghji D. J., Hopkins R., Smith D. W., et al. (1995) beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81, 525–531.
Author information
Authors and Affiliations
Corresponding authors
Additional information
J.T. is Aspirant of the Fonds voor Wetenschappelijk Onderzoek (FWO)
Rights and permissions
About this article
Cite this article
Hartmann, D., Tournoy, J., Saftig, P. et al. Implication of APP secretases in notch signaling. J Mol Neurosci 17, 171–181 (2001). https://doi.org/10.1385/JMN:17:2:171
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:17:2:171